Literature DB >> 1726134

Synthesis of tolerogenic monomethoxypolyethylene glycol and polyvinyl alcohol conjugates of peptides.

M Z Atassi1, T Manshouri.   

Abstract

Recent studies from this laboratory showed that tolerogenic peptide conjugates are very effective reagents for obtaining epitope-specific immunosuppression of antibody responses to immunopathogenic sites on multideterminant complex protein antigens. This paper describes the procedure for synthesis of well-defined conjugates of peptides to monomethoxypolyethylene glycol (mPEG) or to polyvinyl alcohol (PVA). The first step involves succinylation of the hydroxyl groups on the polymers by reaction with succinic anhydride. The polymer is then coupled via the carboxyl of the succinyl group to the alpha-NH2 of the completed peptide on the synthetic resin, while maintaining intact all the side-chain protecting groups on the peptide. The mPEG or PVA-peptide conjugates are cleaved from the resin and purified by standard procedures. This method results in the preparation of conjugates in which one molecule of tolerogenic polymer is coupled to the N-terminal of an otherwise unaltered peptide molecule.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1726134     DOI: 10.1007/bf01025714

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  16 in total

1.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

Authors:  E Kaiser; R L Colescott; C D Bossinger; P I Cook
Journal:  Anal Biochem       Date:  1970-04       Impact factor: 3.365

2.  Preparation and immunochemical properties of methoxypolyethylene glycol-coupled and N-carboxymethylated derivatives of ragweed pollen allergen, antigen E.

Authors:  T P King; L Kochoumian; L M Lichtenstein
Journal:  Arch Biochem Biophys       Date:  1977-01-30       Impact factor: 4.013

3.  Localization and synthesis of the hormone-binding regions of the human thyrotropin receptor.

Authors:  M Z Atassi; T Manshouri; S Sakata
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

4.  A double-blind study comparing monomethoxy polyethylene glycol-modified honeybee venom and unmodified honeybee venom for immunotherapy. I. Clinical results.

Authors:  U Müller; A R Rabson; M Bischof; R Lomnitzer; S Dreborg; A Lanner
Journal:  J Allergy Clin Immunol       Date:  1987-09       Impact factor: 10.793

5.  Suppression of reaginic antibodies with modified allergens. II. Abrogation of reaginic antibodies with allergens conjugated to polyethylene glycol.

Authors:  W Y Lee; A H Sechon
Journal:  Int Arch Allergy Appl Immunol       Date:  1978

6.  Synthesis, isolation, and characterization of conjugates of ovalbumin with monomethoxypolyethylene glycol using cyanuric chloride as the coupling agent.

Authors:  C J Jackson; J L Charlton; K Kuzminski; G M Lang; A H Sehon
Journal:  Anal Biochem       Date:  1987-08-15       Impact factor: 3.365

7.  Induction of in vivo helper activity for murine antibody responses by macrophages pulsed with ovalbumin-monomethoxypolyethylene glycol (OA-mPEG) conjugates.

Authors:  V Holford-Strevens; C J Jackson; J Charlton; K A Akiyama; G M Lang; B G Carter; A H Sehon
Journal:  Cell Immunol       Date:  1987-02       Impact factor: 4.868

8.  Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.

Authors:  A Abuchowski; T van Es; N C Palczuk; F F Davis
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

9.  IgG and IgE antibody patterns after immunotherapy with monomethoxy polyethyleneglycol modified honey bee venom.

Authors:  S L Nordvall; T Uhlin; S Ohman; J Björkander; H J Malling; B Weeke; S Dreborg; A Lanner; R Einarsson
Journal:  Allergy       Date:  1986-02       Impact factor: 13.146

10.  Suppression of reaginic antibodies with modified allergens. I. Reduction in allergenicity of protein allergens by conjugation to polyethylene glycol.

Authors:  W Y Lee; A H Sehon
Journal:  Int Arch Allergy Appl Immunol       Date:  1978
View more
  2 in total

1.  Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.

Authors:  M Z Atassi; K H Ruan; K Jinnai; M Oshima; T Ashizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  PEGylated Chitosan for Nonviral Aerosol and Mucosal Delivery of the CRISPR/Cas9 System in Vitro.

Authors:  Hairui Zhang; Tania F Bahamondez-Canas; Yajie Zhang; Jasmim Leal; Hugh D C Smyth
Journal:  Mol Pharm       Date:  2018-10-01       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.